Stay updated with breaking news from Genome Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Case Western Reserve University and Ionis Pharmaceuticals, Inc. have signed an exclusive license agreement to advance and commercialize a therapeutic approach d
Principal investigator Paul Tesar, of Case Western Reserve University, said the agreement is 'a major step toward a transformational antisense medicine' for patients with Pelizaeus-Merzbacher disease, a rare childhood degenerative disorder of the central nervous system in which coordination, motor abilities and intellectual function progressively deteriorate.
SIR – President Joe Biden said that an “invasion” of Ukraine would mean war, but an “incursion” into Ukraine will only trigger sanctions (report, January 21).
Convergent science is characterized by cross-disciplinary research teams created to tackle big problems and speed the application of new breakthroughs to commercialization. At UNC, the Institute for Convergent Science is at the forefront of this pioneering framework.
Researchers link for the first time mutations in the FANCI gene to the risk of developing ovarian cancer Montreal - Ovarian cancer affects approximately 3000 women per year in Canada. Although most cases are sporadic, there are hereditary forms of ovarian cancer that are largely attributed to mutations in the BRCA1 and BRCA2 genes, which are also involved in breast cancer. However, some families with no known cancer predisposing genes develop multiple cases of ovarian cancer, suggesting that mutations in unknown genes remain to be discovered.